Robot-Assisted versus Laparoscopic Partial Nephrectomy for Giant Sporadic Renal Angiomyolipomas of ≥7 cm: A Propensity Score-Matched Analysis.

Yunqiang Xiong,Wen Deng,Jiahui Long,Xiaoqiang Liu,Ru Chen,Ke Zhu,Bin Fu,Jiayao Wang,Haoxin Jiang,Luyao Chen,Shuang-Zheng Jia

doi:10.1155/2021/6395876

Abstract

Background To compare the perioperative and functional outcomes between robot-assisted partial nephrectomy (RAPN) and laparoscopic partial nephrectomy (LPN) for giant sporadic renal angiomyolipomas (AMLs) of ≥7 cm. Materials and Methods Patients with sporadic renal AMLs of ≥7 cm who underwent RAPN or LPN in the First Affiliated Hospital of Nanchang University between 2015 and 2020 were retrospectively analyzed. Propensity score matching (1 : 1) was performed to adjust for potential baseline confounders. Perioperative and functional outcomes of the RAPN and LPN groups were collected and compared. Result After propensity score matching, no statistically significant differences in baseline characteristics were found between the groups (41 vs. 41). Within the matched cohort, the warm ischemia time (WIT) in the RAPN group was significantly shorter than that in the LPN group (21 vs. 27 min, p < 0.001). In addition, the RAPN group was associated with improved postoperative renal function (72.8 vs. 69.8 mL/min/1.73 m2, p=0.045). WIT and preoperative renal function are independent predictors of renal function at 6 months postoperatively, and renal score and operation method are independent predictors of WIT. Conclusion RAPN and LPN are safe and feasible minimally invasive treatments for sporadic giant renal AMLs, but RAPN is associated with shorter WIT and better postoperative renal functional preservation. WIT and preoperative renal function are independent predictors of renal function at 6 months postoperatively, while the RENAL score and surgical method are independent risk factors to WIT. For giant and complex renal AMLs, RAPN is the first choice when condition permits.

Highlights

Renal AML is a benign mesangial mesenchymal tumor that originated from renal chylous cells [1]
Treatment depends on size, presence of symptoms, and pregnancy status and should be tailored to the patient with the goal of renal function [6]
Most studies about robot-assisted partial nephrectomy (RAPN) vs. laparoscopic partial nephrectomy (LPN) were based on renal AMLs with a diameter of more than 4 cm [11, 12], and no studies focused on renal AML with a diameter of ≥7 cm

Summary

Introduction

Renal AML is a benign mesangial mesenchymal tumor that originated from renal chylous cells [1]. To compare the perioperative and functional outcomes between robot-assisted partial nephrectomy (RAPN) and laparoscopic partial nephrectomy (LPN) for giant sporadic renal angiomyolipomas (AMLs) of ≥7 cm. The RAPN group was associated with improved postoperative renal function (72.8 vs 69.8 mL/min/1.73 m2, p 0.045). WIT and preoperative renal function are independent predictors of renal function at 6 months postoperatively, and renal score and operation method are independent predictors of WIT. RAPN and LPN are safe and feasible minimally invasive treatments for sporadic giant renal AMLs, but RAPN is associated with shorter WIT and better postoperative renal functional preservation. WIT and preoperative renal function are independent predictors of renal function at 6 months postoperatively, while the RENAL score and surgical method are independent risk factors to WIT. For giant and complex renal AMLs, RAPN is the first choice when condition permits

Methods

Findings

Discussion

Conclusion